Here’s What Analysts Are Saying About Teva Pharmaceutical (TEVA) Post Earnings

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best healthcare stocks under $50 to invest in. Barclays ...
Benzinga.com

FTC Crackdown on Teva Pharmaceuticals Over Inhaler Patent Abuse

Last week, the FTC issued a civil investigative demand, effectively a subpoena, to Teva. This demand compels the company to provide internal communications, analysis, and financial data related to the ...
Kalkine Media

Teva Pharmaceutical Industries (NYSE:TEVA) Valuation In Focus Amid Momentum

Teva Pharmaceutical Industries operates in the pharmaceuticals sector, where product mix, regulatory milestones, and ...
Seeking Alpha

Teva: Branded Momentum Clashes With Generic Declines And IRA Headwinds

Teva's Q4 earnings reveal significant headwinds, including declining U.S. generics revenue and rising costs in the API business, impacting overall profitability. Branded drugs like Austedo and Uzedy ...
Investor's Business Daily on MSN

Teva CEO explains 'remarkable story' behind guidance

Teva stock mostly recovered Wednesday on surprisingly light guidance for 2026 following a decisive fourth-quarter beat.
Nasdaq

TEVA Stock Down 10% in a Month: Should You Buy the Dip?

Teva Pharmaceutical Industries Limited’s TEVA stock has declined 10% in a month despite strong third-quarter results announced earlier this month. The company beat estimates for earnings as well as ...